Company Overview and News

2
CRZO / Carrizo Oil & Gas, Inc. DEF 14A

6h sec.gov
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 2
Upvote Downvote

2
CRZO / Carrizo Oil & Gas, Inc. DEFA14A

6h sec.gov
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Upvote Downvote

 
Carrizo Oil & Gas: Time To Make Money

2018-04-16 seekingalpha
Editor's note: Seeking Alpha is proud to welcome Nelson Keusseyan as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more »
Upvote Downvote

 
The Zacks Analyst Blog Highlights: Royal Dutch, SM Energy, Kinder Morgan, Carrizo Oil and SeaDrill

2018-04-11 zacks
Chicago, IL – April 11, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Royal Dutch Shell plc (RDS.A - Free Report) , SM Energy Company (SM - Free Report) , Kinder Morgan Inc. (KMI - Free Report) , Carrizo Oil & Gas, Inc.
Upvote Downvote

4
CRZO / Carrizo Oil & Gas, Inc. PRE 14A

2018-04-10 sec.gov
PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 2
Upvote Downvote

 
Oil & Gas Stock Roundup: RDS.A & SM's Divestment Deals, KMI's Project Suspension & More

2018-04-10 zacks
On the news front, supermajor Royal Dutch Shell plc (RDS.A - Free Report) and upstream player SM Energy Company (SM - Free Report) struck separate divestment deals, while energy infrastructure provider Kinder Morgan Inc. (KMI - Free Report) said that it is halting most activities and associated spending on the Trans Mountain pipeline expansion project.
Upvote Downvote

 
Activist Investor Plans Carrizo (CRZO) Shake-Up, Hikes Stake

2018-04-06 zacks
Carrizo Oil & Gas, Inc. (CRZO - Free Report) has been grappling with low liquidity and high leverage issues. Over the past year, shares of Carrizo have plunged 39%, underperforming the broader industry’s decline of 12.7%.
Upvote Downvote

 
CRZO / Carrizo Oil & Gas, Inc. 8-K (Current Report)

2018-04-06 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Upvote Downvote

 
Activist Investor Targets Carrizo, Wants Permian Focus

2018-04-05 247wallst
Over the past three years or so, the oil and gas exploration and production (E&P) segment has lost about 11% of its market value. Since reaching a high over $69 in June of 2014, shares of Carrizo Oil & Gas Inc. (NASDAQ: CRZO) were down about 78%, closing Wednesday night below $15 a share.
Upvote Downvote

1
CRZO / Carrizo Oil & Gas, Inc. / Kemc Fund Iv Gp, Llc - SC 13D (Activist Investment)

2018-04-05 sec.gov
SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Upvote Downvote

1
CRZO / Carrizo Oil & Gas, Inc. / Kemc Fund Iv Gp, Llc - SC 13D (Activist Investment)

2018-04-05 sec.gov
SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Upvote Downvote

 
Carrizo Oil & Gas (CRZO) Presents At Scotia Howard Weil 46th Annual Energy Conference - Slideshow

2018-03-28 seekingalpha
The following slide deck was published by Carrizo Oil & Gas, Inc. in conjunction with this event.
Upvote Downvote

 
CRZO / Carrizo Oil & Gas, Inc. 8-K (Current Report)

2018-03-28 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Upvote Downvote

 
Carrizo Oil & Gas: Expecting 20% To 25% Exit Rate Production Growth

2018-03-23 seekingalpha
It is attempting to rebuild production now and may end up with 20% to 25% exit rate production growth from continuing operations.
Upvote Downvote

 
Carrizo Oil & Gas (CRZO) Presents At Raymond James 39th Annual Institutional Investors Conference - Slideshow

2018-03-08 seekingalpha
The following slide deck was published by Carrizo Oil & Gas, Inc. in conjunction with this event.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

2h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

CUSIP: 144577103